The Vanguard Group 13D and 13G filings for Novavax, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-11-12 4:46 pm Unchanged |
2024-09-30 | 13G | Novavax, Inc. NVAX |
The Vanguard Group | 15,430,034 9.630% |
0 (Unchanged) |
Filing |
2024-11-04 1:19 pm Purchase |
2024-09-30 | 13G | Novavax, Inc. NVAX |
The Vanguard Group | 15,430,034 9.630% |
869,980![]() (+5.98%) |
Filing |
2024-02-13 5:09 pm Purchase |
2023-12-29 | 13G | Novavax, Inc. NVAX |
The Vanguard Group | 14,560,054 12.260% |
5,715,401![]() (+64.62%) |
Filing |
2023-02-09 11:27 am Purchase |
2022-12-30 | 13G | Novavax, Inc. NVAX |
The Vanguard Group | 8,844,653 10.410% |
852,425![]() (+10.67%) |
Filing |
2022-12-12 3:09 pm Purchase |
2022-11-30 | 13G | Novavax, Inc. NVAX |
The Vanguard Group | 7,992,228 10.180% |
1,095,221![]() (+15.88%) |
Filing |
2022-02-10 08:28 am Purchase |
2021-12-31 | 13G | Novavax, Inc. NVAX |
The Vanguard Group | 6,897,007 9.120% |
1,298,247![]() (+23.19%) |
Filing |
2021-02-10 11:40 am Purchase |
2020-12-31 | 13G | Novavax, Inc. NVAX |
The Vanguard Group | 5,598,760 8.790% |
4,116,901![]() (+277.82%) |
Filing |